Market Trading Guide: Dr. Reddy’s Labs, 3 SmallCaps are shares to buy Tuesday. Sell a display on this larga cap

The Headline Indices of India started the week on a negative memorandum for the third session in a row. The weakness was because of the sales pressure in it, banks and realty socks. During the session the handy resistance was around the 50-bou and stayed under it until the end.

In commentary on the action of the day, Rupak said the senior technical analyst at LKP Securities that the index falls below 24,700 in the midst of rising weakness in the market, indicating a bear handle. “The RSI continues to support the bears with its negative crossover. In the short term, the index can remain under pressure, with a possibility of sliding to 24,550. On the higher side, resistance is seen at 24,800 and 24,950,” said the.

Here are 5 stock recommendations for Tuesday:

Buy Allied blenders on RS 477-478 | Upside down: 6%

Stop loss: RS 461
Goal: RS 505

Allied blenders and distillers (ABDL) shows a higher high formation with a high higher, which indicates a continuation of the upward trend. In the recent session it formed a strong bullish candle near the 9-Eema, which underlined the robust purchase interest rate at lower levels. As long as the stock remains above RS 461, the technical set -up remains constructive. The immediate upward target is placed on RS 505, supported by momentum indicators such as RSI, which continues to float in the bullish zone, and a healthy ADX, which reflects trend strength.

(Drumil Vithlani, technical research analyst at Bonanza)

Buy Navin -Fluor on RS 5,102.50 | Upside down: 5%

Stop loss: RS 4,977
Goal: RS 5.275/5,350

Navin Fluorine International has confirmed an outbreak of completion bottom formation on the monthly graph, which indicates persistent accumulation at higher levels. This bullish breakout is accompanied by a significant increase in volumes, which emphasizes strong institutional participation. The momentum is further validated by technical indicators about the daily and weekly timetables, whereby the RSI trending up and price action is consistently kept over important advanced averages. As long as stocks maintain an end above RS 4,977, the technical prospects remain constructive. In the short term, the stock is ready to test RS 5,275, with an extensive upward potential to RS 5,350.

(Drumil Vithlani, technical research analyst at Bonanza)

Sales ONC Aug-Futures at Rise of RS 240-241 | Disadvantage: 3%

Stop loss: RS 244
Goal: RS 234

The stock recently witnessed a breakdown of his consolidation phase, which points to weakness in the trend. It is also closed under its 20-day EMA, which strengthens the bearish sentiment. Moreover, the RSI is in a bearish crossover, which further indicates the negative momentum. Given these technical indicators, every upward movement in the shares must be considered an opportunity to leave or initiate short positions. Traders are advised to use each reasons as a sales option for lower target levels in the upcoming sessions.

(Vatal Bhuva, technical analyst at LKP Securities)

Buy Dr. Reddy’s Labs RS 1,280-1,290 | Upside down: 5%

Stop loss: RS 1,245
Goal: RS 1,350

The share has witnessed a short-term consolidation outbreak, along with a falling trendline outbreak on the daily graph, which suggests a shift in Momentum. It acts above both the 20-day and 100 days of EMAs, as a result of underlying force. Moreover, the RSI is in a bullish crossover, which supports a positive momentum. With a favorable risk-to-balance ratio, one can consider buying the share, placing a stop-loss at 1245 and striving for a target of 1350.

(Vatal Bhuva, technical analyst at LKP Securities)

Buy Syngen at RS 690-680 | Upside down: 7%

Stop loss: RS 660
Goal: RS 725

The share gave a consolidation breakout on July 17 and has since held over his 20-day EMA, which indicates strength and positive momentum. In the Monday session it also closed above his 100-day EMA, which contributed to the Bullish Sentiment. The RSI is retaining in Bullish Crossover -Territorium, which suggests that constant purchase interest. With these technical indicators that are positively coordinated, it is expected that the stock will be higher and its 200-day EMA zone tests in the short term, making it an attractive candidate for further upwards.

(Vatal Bhuva, technical analyst at LKP Securities)

(Disclaimer: recommendations, suggestions, views and opinions of the experts are their own. These do not represent the views of economic times)